Skip to main content

Brain 18F-FDG–PET/CT Imaging in Hemolytic Uremic Syndrome During and After the Acute Phase

  • Chapter
  • First Online:
  • 4502 Accesses

Abstract

Hemolytic uremic syndrome (HUS) is a multisystemic disease. Besides the kidneys, the central nervous system is clinically involved in 20–50 % of the patients. Common signs of severe CNS injury are seizures, alterations of consciousness, hemiparesis, visual disturbances, and brainstem symptoms. The acute mortality rate is 4–10 %. Morphological brain imaging (CT and MRI) and MRI parametric imaging show structural changes in the basal ganglia, cerebellum, thalami, and brainstem in 20–60 % of HUS patients with clinically severe CNS involvement. The typical 18F-FDG pattern is a significant and diffuse/symmetric impairment of metabolism in the posterior cortex and cerebellum, with minor impairment in the basal ganglia and recovery after clinical healing. A focal/asymmetric pattern of cortical hypoperfusion/hypometabolism in HUS is associated with relevant neurological symptoms/signs in the acute phase.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Herrera P, Valenzuela C, Skarmeta M, Méndez M, Bustos-González A (2012) Enterocolitis, antimicrobials and hemolytic-uremic syndrome in children: Review of a concept. Rev Chilena Infectol 29(3):313–316

    Article  PubMed  Google Scholar 

  2. Rota S, Cravedi P, Remuzzi G, Ruggenenti P (2005) Hemolytic uremic syndrome. G Ital Nefrol 22(Suppl 33):S57–S64

    PubMed  Google Scholar 

  3. Landoni VI, Schierloh P, de Campos Nebel M, Fernández GC, Calatayud C, Lapponi MJ, Isturiz MA (2012) Shiga toxin 1 induces on lipopolysaccharide-treated astrocytes the release of tumor necrosis factor-alpha that alter brain-like endothelium integrity. PLoS Pathog 8(3):e1002632. Epub 2012 Mar 29

    Article  PubMed  Google Scholar 

  4. Steinborn M, Leiz S, Rüdisser K, Griebel M, Harder T, Hahn H (2004) CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr Radiol 34(10):805–810

    Article  PubMed  Google Scholar 

  5. Gómez-Lado C, Martinón-Torres F, Alvarez-Moreno A et al (2007) Reversible posterior leukoencephalopathy syndrome: an infrequent complication in the course of haemolytic-uremic syndrome. Rev Neurol 44(8):475–478

    PubMed  Google Scholar 

  6. Toldo I, Manara R, Cogo P, Sartori S, Murer L, Battistella PA, Laverda AM (2009) Diffusion-weighted imagng findings in hemolytic uremic syndrome with central nervous system involvement. J Child Neurol 24(2):247–250

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Angelina Cistaro MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

Benti, R., Cistaro, A. (2014). Brain 18F-FDG–PET/CT Imaging in Hemolytic Uremic Syndrome During and After the Acute Phase. In: Cistaro, A. (eds) Atlas of PET/CT in Pediatric Patients. Springer, Milano. https://doi.org/10.1007/978-88-470-5358-8_23

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5358-8_23

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5357-1

  • Online ISBN: 978-88-470-5358-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics